National Physical Laboratory

Regulations for regenerative medicine

Translating excellent scientific knowledge into commercial products is challenging, and particularly so in the area of regenerative medicine.

Healthcare sector
Regenerative medicine 'replaces or regenerates
human cells, tissues, or organs to restore or
establish normal function'

Regenerative medicine is a new technology that uses cells to repair damaged tissue. The regulatory framework that it must comply with is still being developed.

Understanding these rules is a major headache for companies which may soon be eased as NPL in collaboration with the University of Leeds has published a 'How to' guide in the March 2011 edition of the journal Advanced Materials: Regenerative Medicine: A Snapshot of the Current Regulatory Environment and Standards.

This document describes the current state of the regulations and standards, many of which have been written by NPL, for further details see Advanced Materials: 23(12), H10-H17, 2011.

This work was funded by the National Measurement System (NMS) and the European Metrology Research Programme (EMRP).

The NMS is the UK's national infrastructure for measurement, which delivers world-class measurement science and technology. It is overseen by the National Measurement Office (NMO), an Executive Agency of the Department for Business, Innovation and Skills and is responsible for stimulating good measurement practice and enabling business to make accurate and traceable measurements, for the benefit of the nation.

Find out more about NPL's work in Materials.

Find out more about NPL's work in Healthcare.

Last Updated: 17 Jan 2014
Created: 28 Mar 2011


Please note that the information will not be divulged to third parties, or used without your permission